奈玛特韦/利托那韦治疗下肾移植受者他克莫司谷浓度个体内变异度及其对血清肌酐的影响.

张彦, 胡林昆, 缪丽燕 - Organ Transplantation/Qi Guan Yi …, 2023 - search.ebscohost.com
… transplant recipients infected by SARS-CoV-2 and treated with … analysis showed that the
increase of Scr level was positively … dose management of oral anticoagulants when initiating …

硫酸软骨素的生物活性及其构效关系研究进展.

蓝伟, 陈建平 - Journal of Food Safety & Quality, 2022 - search.ebscohost.com
… , good degradability as well as less toxic and side effects. … , 发现前3 种 多糖可能通过抑制
SARS-CoV-2 的刺突糖蛋白与宿主… as a novel anticoagulant targeting intrinsic factor Xase …

[HTML][HTML] 新型冠状病毒感染对凝血功能, 肝功能及心功能影响的研究进展

胡国佳, 齐博旭, 孙宝华 - Advances in Clinical Medicine, 2024 - hanspub.org
… 通过微生物测序,确定了此次肺炎是由严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)引起的.SARS-CoV-2属于
一组含有阳性单链RNA基因的包膜病毒[2] ,它属于冠状病毒科(Coronaviridae),…

[图书][B] 医学英语术语通识教程

田俊英, 王燕 - 2022 - books.google.com
… Prognosis is generally good with prompt and adequate … days) for initiation of anticoagulation
therapy and monitoring for any … Laboratory results also indicated that SARS-CoV-2 is similar …

緊急授權適用緊急標準?——以美國COVID-19 期間疫苗緊急授權為例

曾培琪 - 2023 - tdr.lib.ntu.edu.tw
… a virus very similar to SARS-CoV-19, and identifies limitations to … adverse events.Into the
second and third year of observing oral anticoagulants constituting a significant part of adverse

[PDF][PDF] 突发公共卫生事件中信息过载对用户信息规避行为的影响: 基于COVID-19 信息疫情的实证研究

陈琼, 宋士杰赵宇翔 - 情报资料工作, 2020 - qbzl.ruc.edu.cn
… 以新型冠状病毒(SARS-CoV2)所引发的新冠肺炎(COVID-19)疫情为例,作为目前 … The relationship
between low perceived numeracy and cancer knowledge, beliefs, and affect [J]. PloS One…

成人恶性肿瘤患者合并新型冠状病毒感染的诊治建议.

胡毅 - Chinese Journal of Oncology/Zhonghua Zhongliu …, 2023 - search.ebscohost.com
… 口服抗凝药(new oral anticoagulants, NOACs). 低分子肝素是… ⁃ competent SARSCoV2
shedding among patients with … Recurrence of positive SARSCoV2 in patients recovered …